Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools IDH-mutant glioma

IDH-mutant glioma

Programs, trials, and reported response and survival for IDH-mutant glioma.

Data as of 11.07.2026

All studies

Olaparib

OLAGLI

Hospices Civils de Lyon (OLAGLI) · Phase 2 · Completed · Enrollment 35

NCT03561870

ArmReported safety
Olaparib 300 mg BIDn/r

A count stays a count. This page does not turn a count into a percent.